We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
MAP2
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

MAP2

Gene description

Microtubule-associated protein 2

Protein class

FDA approved drug targets
Plasma proteins
Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

8
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Tissue enhanced (glioma)
HPA (cell line):Cell line enhanced (AF22, NTERA-2, SCLC-21H, SH-SY5Y)
HPA (normal tissue):Tissue enriched (cerebral cortex)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Selective cytoplasmic expression in neuronal cells.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining consistent with RNA expression data.

Reliability score

Supported based on 3 antibodies.
HPA008273 , HPA012828 , CAB001984
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in endometrial cancer (unfavourable).
Endometrial cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Tissue enhanced (glioma)

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer

STAINING SUMMARY

HPA008273
HPA012828
CAB001984

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Malignant gliomas and thyroid cancers along with several cases of malignant melanomas, prostate and endometrial cancers displayed moderate to strong cytoplasmic staining. Most other malignant cells were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Malignant gliomas exhibited strong cytoplasmic positivity. A few cases of malignant carcinoid, melanomas and adenocarcinomas of endometrium, prostate and thyroid were moderately stained. Remaining malignant cells were mainly negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Several cases of malignant gliomas were strongly stained. All other malignancies were negative.

GENE INFORMATION

Gene name

MAP2 (HGNC Symbol)

Synonyms

MAP2A, MAP2B, MAP2C

Description

Microtubule-associated protein 2 (HGNC Symbol)

Entrez gene summary

This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The products of similar genes in rat and mouse are neuron-specific cytoskeletal proteins that are enriched in dentrites, implicating a role in determining and stabilizing dentritic shape during neuron development. A number of alternatively spliced variants encoding distinct isoforms have been described. [provided by RefSeq, Jan 2010]

Chromosome

2

Cytoband

q34

Chromosome location (bp)

209424058 - 209734118

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000078018 (version 83.38)

Entrez gene

4133

UniProt

P11137 (UniProt - Evidence at protein level)

neXtProt

NX_P11137

Antibodypedia

MAP2 antibodies

PROTEIN BROWSER

MAP2-001
MAP2-002
MAP2-003
MAP2-006
MAP2-008
MAP2-014
MAP2-015
MAP2-016

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

MAP2-001
ENSP00000353508
ENST00000360351
P11137 [Direct mapping]
Microtubule-associated protein 2
A0A024R407 [Target identity:100%; Query identity:100%]
Microtubule-associated protein
Show all
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000226 [microtubule cytoskeleton organization]
GO:0001578 [microtubule bundle formation]
GO:0002162 [dystroglycan binding]
GO:0005198 [structural molecule activity]
GO:0005515 [protein binding]
GO:0005516 [calmodulin binding]
GO:0005622 [intracellular]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005874 [microtubule]
GO:0005875 [microtubule associated complex]
GO:0007409 [axonogenesis]
GO:0008017 [microtubule binding]
GO:0014069 [postsynaptic density]
GO:0015631 [tubulin binding]
GO:0016358 [dendrite development]
GO:0021954 [central nervous system neuron development]
GO:0031175 [neuron projection development]
GO:0034399 [nuclear periphery]
GO:0043005 [neuron projection]
GO:0043025 [neuronal cell body]
GO:0043198 [dendritic shaft]
GO:0044297 [cell body]
GO:0048813 [dendrite morphogenesis]
GO:0071310 [cellular response to organic substance]
GO:0097442 [CA3 pyramidal cell dendrite]
GO:0097481 [neuronal postsynaptic density]
Show all
1827 aa
199.5 kDa
No 0
MAP2-002
ENSP00000376032
ENST00000392194
P11137 [Direct mapping]
Microtubule-associated protein 2
A0A024R409 [Target identity:100%; Query identity:100%]
Microtubule-associated protein
Show all
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000226 [microtubule cytoskeleton organization]
GO:0002162 [dystroglycan binding]
GO:0005198 [structural molecule activity]
GO:0005515 [protein binding]
GO:0005516 [calmodulin binding]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005874 [microtubule]
GO:0005875 [microtubule associated complex]
GO:0008017 [microtubule binding]
GO:0015631 [tubulin binding]
GO:0021954 [central nervous system neuron development]
GO:0031175 [neuron projection development]
GO:0043005 [neuron projection]
GO:0048813 [dendrite morphogenesis]
Show all
471 aa
49.6 kDa
No 0
MAP2-003
ENSP00000199940
ENST00000199940
P11137 [Direct mapping]
Microtubule-associated protein 2
Show all
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000226 [microtubule cytoskeleton organization]
GO:0002162 [dystroglycan binding]
GO:0005198 [structural molecule activity]
GO:0005515 [protein binding]
GO:0005516 [calmodulin binding]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005874 [microtubule]
GO:0005875 [microtubule associated complex]
GO:0008017 [microtubule binding]
GO:0015631 [tubulin binding]
GO:0021954 [central nervous system neuron development]
GO:0031175 [neuron projection development]
GO:0043005 [neuron projection]
GO:0048813 [dendrite morphogenesis]
Show all
559 aa
59 kDa
No 0
MAP2-006
ENSP00000376031
ENST00000392193
A8MZ31 [Direct mapping]
Microtubule-associated protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001578 [microtubule bundle formation]
GO:0008017 [microtubule binding]
GO:0021954 [central nervous system neuron development]
Show all
106 aa
11.2 kDa
No 0
MAP2-008
ENSP00000388824
ENST00000452717
H7BZB9 [Direct mapping]
Microtubule-associated protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001578 [microtubule bundle formation]
GO:0008017 [microtubule binding]
GO:0021954 [central nervous system neuron development]
Show all
208 aa
21.8 kDa
No 0
MAP2-014
ENSP00000392164
ENST00000447185
P11137 [Direct mapping]
Microtubule-associated protein 2
Show all
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000226 [microtubule cytoskeleton organization]
GO:0002162 [dystroglycan binding]
GO:0005198 [structural molecule activity]
GO:0005515 [protein binding]
GO:0005516 [calmodulin binding]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005874 [microtubule]
GO:0005875 [microtubule associated complex]
GO:0008017 [microtubule binding]
GO:0015631 [tubulin binding]
GO:0021954 [central nervous system neuron development]
GO:0031175 [neuron projection development]
GO:0043005 [neuron projection]
GO:0048813 [dendrite morphogenesis]
Show all
1823 aa
199.1 kDa
No 0
MAP2-015
ENSP00000355290
ENST00000361559
P11137 [Direct mapping]
Microtubule-associated protein 2
A0A024R409 [Target identity:100%; Query identity:100%]
Microtubule-associated protein
Show all
Predicted intracellular proteins
Plasma proteins
FDA approved drug targets
   Small molecule drugs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000226 [microtubule cytoskeleton organization]
GO:0002162 [dystroglycan binding]
GO:0005198 [structural molecule activity]
GO:0005515 [protein binding]
GO:0005516 [calmodulin binding]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0005874 [microtubule]
GO:0005875 [microtubule associated complex]
GO:0008017 [microtubule binding]
GO:0015631 [tubulin binding]
GO:0021954 [central nervous system neuron development]
GO:0031175 [neuron projection development]
GO:0043005 [neuron projection]
GO:0048813 [dendrite morphogenesis]
Show all
471 aa
49.6 kDa
No 0
MAP2-016
ENSP00000409969
ENST00000445941
E7EV03 [Direct mapping]
Microtubule-associated protein 2
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001578 [microtubule bundle formation]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0008017 [microtubule binding]
GO:0021954 [central nervous system neuron development]
Show all
567 aa
61.8 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.